YG PRESS NEWS – Revolutionizing healthcare: the point-of-need microfluidic testing are a game-changer
Product Related
Will the molecular diagnostics be the driver of the microfluidics PoNT market to US$16.2 billion in 2028?
- The PoN microfluidic testing market is expected to reach US$16.2 billion, with a 7.0% CAGR22-28.
- COVID-19 was an accelerator of PoNT solutions adoption.
- Almost 91% of the PoN microfluidic testing market (in value) is held by ten players.
- Innovations in PoNT to meet market demands for accuracy, speed, ease of use, and affordability.
According to Yole Intelligence, part of Yole group, in the Microfluidics based Point-of-Need Testing 2023 report, PoN microfluidic-based tests have gained significant traction in hospitals, emergency rooms, and low-income countries. The year 2022 witnessed a remarkable milestone with the shipment of 631 million modules, and this figure will escalate to 886 million by 2028, exhibiting a CAGR of 5.8% from 2022 to 2028. Moreover, in terms of revenue at the module level, the global market reached a substantial value of approximately US$10.8 billion in 2022. Looking ahead, Yole Intelligence’s forecasts indicate a robust growth trajectory, with the market poised to expand to US$16.2 billion by 2028, reflecting a CAGR of 7.0% from 2022 to 2028. These revenue projections underscore the immense economic potential and opportunities associated with PoN microfluidic-based testing in the healthcare sector… For more information about this analysis, please contact us!
Titre du visuel
june 2021You have to be registered to download our medias.
Usage restriction: Images may not be used against the interests of Yole Développement (Yole Group) and its entities, Yole Intelligence, or System Plus Consulting (Yole SystemPlus). For more information, please contact the Public Relations team.
INFORMATIONS
Copyright : © Yole Développement, 2023
Licence : Images can be used online and for printing, without modification
Thematic(s) :